Medical Devices

Friday, 3 March 2017

Refurbished Medical Imaging Equipment Market: New Market Research Report Announced; Global Industry Analysis 2016 - 2024

Refurbished equipment are generally refined/repaired devices with improvements (structure, safety) into existing or used ones. Basically, refurbished equipment are the new version of the old equipment in terms of better safety, efficacy, and user-friendliness without changing its recommended use as per original registration. Considering the growing pollution and limited energy resources, refurbishing is preferable to extend equipment service life from an environmental standpoint.

Browse Market Research Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20717

The global refurbished medical imaging equipment market has been segmented based on device and region. The five major categories of refurbished medical imaging equipment include magnetic resonance imaging (MRI), X-ray, computed tomography (CT), ultrasound, and nuclear imaging equipment. MRI and CT devices accounted for majority of the global refurbished medical imaging equipment market. Manufacture of MRI and CT devices require a large number of skilled personnel. Hence, it is better to refurbish the above mentioned devices at a lower cost. Major modalities used for diagnosing cardiovascular disease include CT scanners, magnetic resonance imaging (MRI), and nuclear imaging equipment. Rising incidence of chronic diseases across the globe is increasing demand for cost-effective and efficient diagnosis procedure. This in turn is driving demand for refurbished medical imaging devices. Moreover, a high number of tuberculosis (TB) patients are present in the developing and under-developed countries. Most of the demand for X-ray and MRI equipment comes from these countries as people in these countries prefer cost effective medical treatment. Hence, emerging economies are contributing significantly to the growth of the refurbished medical imaging equipment market.

Cost constraints and cost effective medical treatment are the major factors driving the market. Budget pressures are driving more prudent investments in refurbished medical imaging equipment and support services. Refurbished imaging equipment dodges the new medical device tax which encourages manufacturers, producers, and importers to invest in this market. The long life of medical devices is another factor fueling the growth of the market. Rise in incidence of several diseases such as respiratory, oral, orthopedic, and cardiovascular has increased demand for diagnosis and diagnostic equipment across the world. New global regulation threat to the shipment of used medical equipment for refurbishment and low adoption rate by physicians are the major factors hampering market growth. Environmental benefits pertaining to medical imaging equipment are likely to offer significant opportunities in the market.

Fill the form to gain deeper insights on this market: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20717

Geographically, the refurbished medical imaging equipment market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Asia Pacific is expected to be the fastest growing market for refurbished medical imaging equipment due to low purchasing parity. High cost of digital radiology devices such as X-ray systems, MRI scanners, and CT scanners is a major deterrent for market growth in emerging countries. China and India are expected to be the largest contributors to market growth, as these countries are witnessing rapid development in health care infrastructure. In these regions, complementary systems such as ultrasound were deployed instead of the costly digital radiology devices. Several international and local companies are investing in Asia Pacific to tap the highly potential market in the region. The refurbished medical equipment market in Latin America is also likely to experience significant growth. This is attributed to rapid rise in health care infrastructure (health care budget and health care facility) and rise in disposable income of people in the region, especially Brazil and Mexico.

Major players operating in the refurbished medical imaging equipment market include Atlantis Worldwide, Block Imaging, Siemens Healthineers, Philips Healthcare, GE Healthcare, Carestream Health, Inc., FUJIFILM Holdings Corporation, Shimadzu Corporation, Hitachi Medical Corporation, and Toshiba Corporation.

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Hemofiltration Systems Market: Technologies, Markets and Players

Hemofiltration is a renal replacement therapy, generally used in intensive care settings. The procedure is carried out for acute kidney injury, multiple organ dysfunction, and other renal disorders. The process involves filtration of patient’s blood. The patient’s blood passes through a filtration circuit, a set of tubing, through a semipermeable membrane (filter). The solutes and other impurities are separated from the blood by convection. The replacement fluid is added to the blood and it is returned to the patient’s body via a machine (a set of tubing). A positive hydrolyte pressure drives solutes and water from blood compartment to the filtrate compartment. The hemofiltration process takes several hours to complete, during which the blood is pumped on continuous basis through the membrane filter and back to the patient. The components that are small enough to pass through the filter pores are removed from the blood.

Rising geriatric population, continuous advancements in the technologies associated with hemofiltration procedures, and high prevalence of acute kidney injury are the major factors expected to drive the hemofiltration systems market during the forecast period. However, high procedural cost, the complexity in the process, and lack of trained and qualified personnel in developing economies are likely to hamper the growth of the hemofiltration systems market from 2016 to 2024.

Obtain Report Details: http://www.transparencymarketresearch.com/hemofiltration-systems-market.html

The global hemofiltration systems market has been segmented based on modality and end-user. In terms of end-user, the global hemofiltration systems market has been divided into hospitals, outpatient settings, and others. The hospitals segment dominated the global hemofiltration systems market in 2015, attributed to the availability of well-equipped facilities in the intensive care units, positive reimbursement policies, and rising number of patients with acute kidney injury and renal dysfunction. The segment is expected to continue to dominate the hemofiltration systems market during the forecast period driven by technological advancements in the procedures.

Based on modality, the global hemofiltration system market has been segmented into continuous hemofiltration and intermittent hemofiltration. Intermittent hemofiltration is a short duration process, normally takes three to four hours to complete, and the replacement fluid is prepared online from the dialysis solution. However, continuous hemofiltration procedure requires eight to 12 hours for completion, as the substitution fluid used in this process (CHF) is commercially prepared, and sterile to avoid regulatory issues related to on-line creation of substitution fluid from dialysis solution. The continuous hemofiltration systems segment held the largest share of the hemofiltration systems market in 2015 owing to high adoption rate among patients. The segment is anticipated to lead the market during the forecast period, due to improving health care infrastructure and rising incidence of acute renal injuries and failures.

Geographically, the global hemofiltration systems market is broadly classified into five regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America held the largest market share in terms of revenue in 2015, owing to the favorable reimbursement policies in hospitals, technological advancements in the renal replacement procedures, and high adoption rate among the population for healthcare facilities. The region is expected to continue to dominate the global market during the forecast period. This is attributed to the presence of key players in the market. Asia Pacific is likely to be the fastest growing market in terms of CAGR, due to the growing geriatric population, rising focus of multinational industries on the emerging economies, and attempts made by government and private organizations to improve health care infrastructure facilities.

Fill the form for an exclusive sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20768

Major players in the global hemofiltration systems market are Asahi Kasei Corporation, Baxter International, Infomed SA, Fresenius Medical Care AG & Co. KGaA, B. Braun Melsungen AG, Nikkiso Co., Ltd, Nipro, Medica S.p.A., NxStage Medical, Inc., and Bellco. Companies focus on the geographic expansion, acquisition, and partnerships as key business strategies.

Contrast Media/Contrast Agent Market Segment Forecast up to 2024

Contrast medium or contrast agent is a substance used in medical imaging to enhance the contrast of fluids or structures inside the body. These help in better imaging of anatomical structures and organs by increasing the image contrast. Hence, these are helpful in diagnostic methods such as CT scan and in some critical surgeries. The global contrast media or contrast agent market is a fairly mature, and is expected to witness strong growth driven by increasing imaging diagnosis and surgical procedures. The contrast media or contrast agent market has evolved significantly over the last century. Initially, radiologists and practitioners used barium and iodine-based agents. Advancement in nanotechnology has enabled usage of gold nanoparticle along with radiopharmaceuticals.

Growth of the contrast media or contrast agent market is driven by increasing demand for image guided diagnostics and procedures, rising mortality of chronic diseases such as cancer, gastrointestinal disorders, and cardiac diseases, and growing demand for image guided surgical procedures. Growth of the market can also be attributed to factors such as increasing approvals for contrast agents and rising number of private and government diagnostic centers for improving diagnostic imaging services. Moreover, increasing research studies about applications of various contrast agents and strong pipeline products of the companies are projected to create new opportunities in the global contrast media or agent market.

Obtain Report Details: http://www.transparencymarketresearch.com/global-contrast-media-contrast-agents.html

Advancement in technology and use of advanced techniques such as gas micro bubble technology in MRI imaging are likely to contribute to the growth of the market. Global reforms regarding better healthcare and radiopharmaceuticals, and increasing investments in the contrast media market are fueling market growth. However, sluggish economies, effecting sales of contrast media in medical reform, and fluctuating economies of regions like Europe may hamper the growth of the market.

The contrast media or contrast agent market can be segmented based on product, procedure, application, route of administration, indication, and region. The market can be segmented into barium-based contrast media, gadolinium-based contrast media, and iodinated contrast media. The iodinated contrast media segment accounts for the major market share due to high usage of iodinated agents in CT scan. Based on product type, the contrast media or agent market can be segmented into magnetic resonance imaging, ultrasound, X-ray/computed tomography (CT), and catheterization laboratory. In terms of application, the market can be categorized into interventional cardiology, radiology, and interventional radiology. Based on route of administration, the market can be segmented into injectable contrast media, oral contrast media, urethral contrast media, and rectal contrast media. The injectable contrast media segment accounted for the major share of the market due to increasing number of CT scans and MRIs performed. In terms of indication, the market has been segmented into nephrological disorders, neurological disorders, musculoskeletal disorders, gastrointestinal disorders, cardiovascular disorders, and oncology.

The global contrast media or contrast agent market has been segmented into five main regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America and Europe are mature markets for contrast media and contrast agents. Strong infrastructure, improved MRI techniques in cardiovascular diseases, advanced cath-lab and reimbursement policies for contrast media or agent are the factors contributing to the high growth in these regions. Asia Pacific is expected to experience high growth due to increasing number of cardiac and other disorders, and advancement in technology. This region offers manufacturers lucrative opportunities for investment in the market.

Fill the form for an exclusive sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=876

Major players in the contrast media or contrast agent market are GE Healthcare, Bracco Imaging S.p.A., Guerbet Group, Bayer HealthCare, CMC Contrast AB, Lantheus Medical Imaging, Daiichi Sankyo, nanoPET Pharma GmbH, and Subhra Pharma Private Limited, among others.

Thursday, 2 March 2017

Hospital Infectious Disease Testing Market Outlook and Forecast up to 2024

Hospital infectious disease testing is a procedure to identify hospital acquired/related infections. Hospital infections are among the most prominent challenges faced by health care delivery systems across the globe. Hospital infectious diseases are considered a significant cause of death globally. These are acquired while receiving health care treatment. Hospital infectious diseases tests are performed by health care professionals, especially clinical laboratory technicians, for the diagnosis of infections.

Based on test type, the global hospital infectious disease testing market has been broadly segmented into:

Urinary tract infection (UTI)
Surgical site Infection
Pneumonia
Bloodstream infection
MRSA
Others

Read Full Report: http://www.transparencymarketresearch.com/hospital-infectious-disease-testing-market.html

The UTI segment accounted for the major share of the hospital infectious disease testing market, followed by surgical site infections and pneumonia. Hospital infectious diseases are required to be closely monitored due to increase in antimicrobial resistance in some regions. Automated urine microscopy is the most preferred diagnostic tool adopted by clinical technicians for UTI. Prevalence of pneumonia and deaths associated with it are increasing gradually. Other hospital infections include cardiovascular, systemic, joint and bone, respiratory, and ENT (enteric) infections.

The hospital infectious disease testing market has experienced strong growth in the last decade due to factors such as increased awareness about growth in the incidence of infections globally and development of innovative prevention and treatment solutions. Major factors driving the market are establishment of quality government guidelines and uniform code for prevention of hospital infectious diseases. Lack of funding and skilled manpower in developing countries and lack of stringent guidelines and framework to control the morbidity rate of hospital infections are restraining the hospital infectious disease testing market. Lack of controlling authorities and controlling programs in lesser developed regions is another major factor hampering market growth. Technological development of molecular diagnostics and passage of the Patient Care and Affordable Care Act in the U.S. are likely to offer significant opportunities in the market in the near future.

Geographically, the global hospital infectious disease testing market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for the largest share of the market due to growing patient awareness, favorable initiatives taken by the federal government, and large number of market players based in the region. The hospital infectious disease testing market in Europe is mature due to presence of strong and active hospital infection control and prevention authorities and guidelines such as the NHS in the U.K. Moreover, Europe is considered the hub for the global geriatric population. It is observed that geriatrics are more prone to various infections. This is likely to increase demand in Europe. Asia Pacific is a lucrative market for hospital infectious disease testing products as the overall prevalence of the infections in this region is high. Moreover, stringent guidelines have been set for the prevention and control of such conditions in the health care infrastructure in this region. Countries such as China, India, Japan, Thailand, Australia, and the Philippines are expected to be the major contributors to the hospital infectious disease testing market in Asia Pacific. Latin America and Middle East & Africa are considered the emerging markets for hospital infectious disease testing. This is attributed to increasing investment by governments for effective health care infrastructure in the region.

Download exclusive Sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20612

Key players operating in the hospital infectious disease testing market include Abbott Laboratories, Alere, Inc., Thermo Fisher Scientific, Inc. (Life Technologies Corporation), Becton, Dickinson and Company, bioMérieux SA, F. Hoffmann-La Roche Ltd., Hologic, Inc., Siemens Healthineers, Diatherix Laboratories, Inc., Meridian Bioscience, Inc., Cepheid, Inc., and QIAGEN.

Sternal Retractor Market: Applications and Global Markets

Sternal retractor is a rib separator. It is a surgical device specifically used and designed for rib and thoracic surgery. It is made of stainless steel. Sternal retractor is a rack and pinion surgical instrument used in the repair of congenital heart disease. Sternal retractor is used for cardiothoracic surgical procedures. It is most effectively used as a sternum separator allowing access to the surgical field and is uniquely designed with a self-retaining rack and pinion action for optimal function. Sternal retractors are used to separate the edges of surgical wounds. These are also used to hold back body organs to avoid distraction during incision. Generally, retractors are handheld and self-retaining tools that do not need to be held after insertion by having two of more blades opposing each other or hooks which are separated by ratchet, spring, worm gear, or other method to pull on contrary sides of incision. Sternal retractors have fenestrated blades and hand-cranked lever to separate the arms.

Read Full Report: http://www.transparencymarketresearch.com/sternal-retractor-market.html

Retractors have been used as surgical instruments since long. It is also known as Finochietto retractor. Usage of the tool has evolved and many changes taken place in its design and making. The instrument was first invented by a French surgeon Theodore Truffier and later on modified by Enrique Finochietto, a surgeon from Argentina. The sternal retractors system applies constant traction and provides uninterrupted visibility of the operating site up to the edge of the rib cage. Hence, it has significant importance in surgical processes. The use of sternal retractors is universal in open thoracic surgery. Therefore, the global sternal retractors market is expected to witness significant growth in the near future. Technological advancements in instrumentation such as introduction of automated sternal retractors which validate more superior results are likely to propel the market in the next few years.

The global sternal retractors market has been segmented based on device type, end-user, and region. In terms of device type, the market has been segmented into Tuffier sternal retractor, Harken sternal retractor, Burford-Finochietto sternal retractor, Nelson sternal retractor, and others. Sternal retractors are available in different sizes and number of blades. Increasing number of surgeries and usefulness of the instrument to make undistracted incision make it more preferable by surgeons. Low cost of the product is also a major driver of the global sternal retractor market.

Based on end-user, the market has been segmented into hospitals, ambulatory surgical centres, and orthopaedic clinics. Thoracic surgeries are majorly processed in hospitals, hence the hospitals segment accounts for a significant share of the sternal retractor market. The ambulatory surgical centres segment holds the second largest share of the market. High patient preference for hospital due to proper care and treatment under the observation of skilled doctors is likely to boost the hospitals segment.

Download exclusive Sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20441

Geographically, the sternal retractor market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the globally market. This is attributed to high rate of surgeries, well-established health care infrastructure, and increase in demand for surgical instruments. Europe holds the second largest share of the sternal retractor market. Asia Pacific is expected to be the most promising market due to large patient pool and rising number of surgeries.

The global market for the sternal retractor is highly fragmented. Key players operating in the global sternal retractor market are B. Braun Melsungen AG, Cardivon Surgical, Inc., Novo Surgical, Inc., Sklar Instrument, MEDICON eG, and others.

Electrosurgical Liposuction Pump Market: Technological breakthroughs, Value chain and stakeholder analysis by 2024

Electrosurgical liposuction is a process of removal of fat under the tissues by the application of high frequency alternate current on the tissue. It is a process of applying radiofrequency alternate current to destroy large amount of tissue. It can be either applied in a monopolar form in which the current passes through the body or in a bipolar form in which the current is passed through the tines of the forceps. In the process of electrosurgical liposuction, electric energy is applied on the biological tissue to cut, coagulate, devitalize, and thermofuse (vessel sealing). Furthermore, it is one of the earliest modes of treatment for the removal of adipose fat from the body.

Read Full Report: http://www.transparencymarketresearch.com/electrosurgical-liposuction-pump-market.html

Growth in esthetic awareness and increase in obesity contribute to the growth of the electrosurgical liposuction pump market. Change in lifestyle and dietary habits and sedentary lifestyle contribute to the increasing obesity, which are likely to aid to the growth of the electrosurgical liposuction pump market. According to the Centers for Disease Control and Prevention (CDC), more than one-thirds of the U.S. population are obese. Furthermore, obesity is higher in middle-aged and old-aged population. In addition, certain medical conditions, such as dysfunctioning of thyroid gland which might lead to obesity, are estimated to contribute to the growth of the market. However, the high cost of esthetic treatment and availability of non-invasive liposuction procedures are likely to have a negative impact on the electrosurgical liposuction pump market. In addition, this process is associated with various side effects such as scarring, increased time needed for coagulation with bipolar technique, and incidental tearing of adjacent blood vessels.

The global electrosurgical liposuction pump market can be segmented on the basis of technique, product type, end-user, and geography. On the basis of technique, the market can be segmented into monopolar technique and bipolar technique. Based on the product type, the market can be segmented into aspiration pump, cannula, and other accessories. The aspiration pumps are anticipated to be the leading segment of the market. On the basis of end-user, the market can be segmented into hospitals, ambulatory surgical centers, and dermatology clinics. Based on the end-user, the hospitals segment is projected to continue its dominance during the forecast period.

Download exclusive Sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20369

Geographically, the electrosurgical liposuction pump market is distributed over North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is anticipated to record a high market share of the electrosurgical liposuction pump market. This can be attributed to well-developed health care infrastructure, technological advances, and favorable reimbursement scenario. North America is followed by Europe in terms of market share. However, the growth of the Europe market is anticipated to be affected by the sluggish economic growth. Asia Pacific is expected to record a robust CAGR during the forecast period. This increase in CAGR can be attributed to the significant contribution from the emerging countries such as China and India. In addition, India is accounted to be the third most obese country globally. Rise in obesity, increase in esthetic awareness among people, and growth in disposable income are expected to contribute to the growth of the Asia Pacific market.

The major players operating in the electrosurgical liposuction pumps market include Erbe Elektromedizin GmbH, Eurosurgical, Nouvag AG, DRE Medical, Inc., AART, Inc., Black and Black Surgical, ORDISI SA, HK Surgical Inc., MD Resource Corp., Amritt, Inc., ATMOS MedizinTechnik GmbH & Co. KG, and Cheiron, Inc.

Non-Invasive Skin Tightening Devices Market size and Key Trends in terms of volume and value 2016-2024

Skin tightening is one the most popular esthetic treatments. Several skin tightening techniques have been developed. Two major methods for skin tightening are invasive (requires use of a catheter, needle, or other instruments) and non-invasive (does not require any instrument). Hence, most of the invasive methods are surgical and non-invasive methods are non-surgical or pain free (negligible pain). Invasive skin tightening treatments include rhytidectomy and blepharoplasty. Presently, several techniques are available that help patients fight against sagging and loose skin without surgery. Non-invasive skin treatment is pain free, low risk, and does not require extended time/prolonged time.

Read Full Report: http://www.transparencymarketresearch.com/non-invasive-skin-tightening-devices-market.html

Based on type of device, the non-invasive skin tightening devices market can be segmented into fractional devices, fractional lasers, light emitting diodes (LEDs), micro-focused ultrasound, micro-current, micro-needling, radio frequency, and ultrasound. Fractional devices have been used in facial rejuvenation treatment for the last two decades. These devices use laser energy for mechanical breakdown. Fractional lasers are non-invasive skin treatment devices in use since 2004. Fractional lasers make use of energy in either heating the non-ablative or removing ablative portions of skin by passing light beam through the difractionated microlens. This results in fewer complications, rapid re-epithelialization, and consistent results. LED non-invasive skin tightening devices use light to generate the energy necessary for regeneration and repair of human cells. The limited heat effect makes them safer to be used in non-medical treatments and for home usage of patients. Micro-focused ultrasound devices deliver heat to the deep and sub-dermal connective tissue in focused areas. Microcurrent devices use low level electrotherapy to tone muscles in the skin and increase circulation to achieve youthful appearance. Radiofrequency device emits energy in the form of electromagnetic wave, which later converts into heat. These produce the heat waves into the skin to stimulate the production of collagen, resulting in skin tightening. Radiofrequency devices hold the largest market share of the non-invasive skin tightening market, as these are most commonly used for fat reduction. There are various radio frequency non-invasive skin tightening devices, which differ in terms of the amount of energy produced by them and methods used to produce energy.

Increasing demand for pain-free skin tightening treatment among patients is one of the major drivers of the non-invasive skin tightening devices market. Moreover, dermatologists prefer non-invasive skin tightening devices due to low risk involved. Patients and doctors also demand little downtime for the treatment. Easy-to-use non-invasive skin tightening devices enable doctors to safely delegate treatment to nurses or medical professionals leading to the growth of the non-invasive skin tightening devices market. High cost of these devices is a major restraint of the market. Understanding the complete usage and application of devices is also difficult. Development of more advanced, efficient, and reliable devices is likely to offer significant opportunities in the market.

Download exclusive Sample of this report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20576

Geographically, the non-invasive skin tightening devices market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for the largest share of the market owing to increasing health awareness and technological advancement in the region. Europe is the second largest market for non-invasive skin tightening devices attributed to the presence of large geriatric population in the region. Asia Pacific is the fastest growing market due to increasing adoption of new health care technologies, improving health care infrastructure, and rising population susceptible to various skin diseases and conditions.

Key players in the non-invasive skin tightening devices market include SharpLight Technologies Ltd., Project E Beauty, Solta Medical, Venus Concept, Syneron, BTL, Endymed, and Pollogen Ltd.